MD, L. J., MD, H. Y., & PhD, C. T. Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab plus Bevacizumab Combination Therapy. SAGE Publishing.
Chicago Style (17th ed.) CitationMD, Long-Bin Jeng, Horng-Ren Yang MD, and Chiao-Fang Teng PhD. Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab Plus Bevacizumab Combination Therapy. SAGE Publishing.
MLA (9th ed.) CitationMD, Long-Bin Jeng, et al. Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab Plus Bevacizumab Combination Therapy. SAGE Publishing.
Warning: These citations may not always be 100% accurate.